Diabetes Alongside Specific Disabilities

Diabetes alongside specific disabilities: where the two conditions interfere with each other

Generic diabetes advice assumes a generic body. Put diabetes alongside a specific disability and the advice sometimes stops working — occasionally it inverts.

In cystic fibrosis-related diabetes, the high-calorie diet is maintained rather than restricted. In spinal cord injury at or above T6, the sweating and palpitations of a hypo look identical to autonomic dysreflexia, and the two have opposite treatments. In older people with dementia, the most common diabetes problem is not undertreatment but overtreatment. In Duchenne muscular dystrophy, the steroids that preserve function cause the diabetes.

This guide is the condition-by-condition version: where the mechanism is different, where standard advice misleads, and what to watch for.

This comes from a disability provider operating throughout New South Wales, not a diabetes service, and none of it is medical advice — the interactions described here are reasons to raise specific questions with a treating team, not conclusions to act on.

The overview

Down syndrome

The mechanism. Down syndrome carries an elevated risk of type 1 diabetes — an autoimmune condition, not a lifestyle one — with onset often earlier than in the general population. Separately, obesity and type 2 diabetes risk are also raised, through reduced resting metabolic rate, thyroid dysfunction and activity levels.

What gets missed: autoimmune conditions cluster. Down syndrome is associated with autoimmune thyroid disease and with coeliac disease as well as type 1 diabetes. A person with one of them warrants attention to the others, and the symptom pictures overlap confusingly — fatigue, weight change and gastrointestinal symptoms could be any of the three, or the disability, or none of them.

What to do: thyroid function testing at the intervals recommended for Down syndrome, which is a standing recommendation independent of diabetes; consideration of coeliac screening; and glucose testing as part of the annual health assessment. There is a separate guide on this site covering Down syndrome health checks.

The practical complication: a young person with Down syndrome and type 1 diabetes needs insulin for life from the point of diagnosis, which brings the whole of the consent, education and support-worker competency picture forward into childhood and adolescence.

Prader-Willi syndrome

The mechanism. Hyperphagia — persistent, severe hunger that is not relieved by eating — is a core feature of the syndrome. Combined with reduced energy requirements and low muscle mass, it produces high rates of obesity and type 2 diabetes.

What matters most. Hyperphagia is not a behaviour the person is choosing and it does not respond to education or willpower. Unrestricted food access in Prader-Willi syndrome is genuinely dangerous — rapid severe obesity, type 2 diabetes, and in some cases acute life-threatening events. Food security measures including secured food storage and supervised access are standard, internationally accepted management.

And in the NDIS context those measures are a regulated restrictive practice — environmental restraint — requiring authorisation under the relevant state or territory process, a behaviour support plan naming the practice, and reporting to the Commission. This is the clearest example in the whole of this library of a restriction that is clinically correct and still needs proper authorisation. There is a full guide on that question here.

Also relevant: growth hormone treatment, which affects body composition and glucose metabolism, and which needs monitoring alongside any diabetes management.

Spinal cord injury

The mechanism. Substantial loss of muscle mass below the level of injury, a fall in resting metabolic rate, reduced capacity for physical activity, and a shift in body composition toward fat. In higher injuries, loss of sympathetic control limits the heart rate response to exercise. The result is elevated rates of insulin resistance and type 2 diabetes, appearing earlier than in the general population.

What gets missed, one: BMI lies. Reduced muscle mass means a person can have a body mass index in the normal range alongside substantial adiposity. Read against general population thresholds, BMI provides false reassurance. Waist circumference and clinical assessment are more informative, and lower BMI thresholds are generally considered appropriate after spinal cord injury.

What gets missed, two — and this is the dangerous one. In injuries at or above T6, the symptoms of hypoglycaemia overlap almost exactly with the symptoms of autonomic dysreflexia: sweating, pallor, anxiety, a pounding headache, feeling unwell. The two conditions have completely different causes and completely different treatments, and in a person who cannot easily describe what they are experiencing, telling them apart matters.

The practical answer is that blood glucose and blood pressure should both be checked when somebody with a spinal cord injury at or above T6 and diabetes becomes unwell in this way. Not one or the other. A dysreflexia protocol that does not mention glucose, and a hypo protocol that does not mention blood pressure, will each miss half the time.

What gets missed, three: feet. Spinal cord injury already means absent sensation and absent weight-shifting. Add diabetic neuropathy and peripheral arterial disease and the foot risk compounds substantially. Somebody with both conditions needs the foot and skin surveillance described in the spinal cord injury pressure injury guide and the diabetic foot surveillance described in the diabetes foot guide here — and the two should be one routine, not two.

And injection sites. Insulin injected into an area with absent sensation means the person will not feel a reaction, an infection or an injection into lipohypertrophy. Site rotation and someone actually looking at the sites matter more here.

Cerebral palsy in adults

The mechanism. Reduced muscle mass, limited physical activity for structural reasons, long-term medications, and in some people a history of feeding difficulty and altered nutrition. Adults with cerebral palsy have elevated cardiometabolic risk.

What gets missed: adult cerebral palsy care in Australia is thin. Paediatric services are good; adult services frequently do not exist in any organised form, and cardiometabolic screening in adults with cerebral palsy is not routine anywhere. A 38-year-old with cerebral palsy may not have had a glucose, lipid or blood pressure check in a decade.

What to do: treat cardiometabolic screening as something that needs booking rather than assuming it happens. BMI is again unreliable where muscle mass is low. Where there is intellectual disability as well, the annual health assessment under MBS item 707 is the mechanism.

Myotonic dystrophy

Insulin resistance is a feature of the condition rather than a complication of lifestyle — it arises from the underlying genetic mechanism. Diabetes in myotonic dystrophy therefore needs managing in a context where cardiac conduction abnormalities, respiratory muscle weakness and dysphagia may all be present, and where anaesthetic risk is elevated.

There is a detailed guide on myotonic dystrophy in the muscular dystrophy library on this site. The point for this set: the diabetes is expected, it should be looked for, and it sits inside a condition with several other serious considerations that affect how it is managed.

Cystic fibrosis-related diabetes

This is where standard advice inverts, which is why it is worth knowing even if it is uncommon.

Cystic fibrosis-related diabetes is a distinct entity — not type 1 and not type 2 — caused by damage to the pancreas from the underlying disease. It becomes more common with age and affects a substantial proportion of adults with cystic fibrosis.

The counterintuitive part: in cystic fibrosis, maintaining weight and nutrition is a priority because it is associated with better lung function and survival. So the high-calorie, high-fat diet that cystic fibrosis management requires is generally maintained, and the diabetes is managed with insulin rather than by restricting food.

Telling somebody with cystic fibrosis-related diabetes to cut calories, as generic diabetes advice would, is the wrong advice and potentially a harmful one. Anybody supporting a person with both conditions should be working from the cystic fibrosis team’s plan, which will reflect this.

Corticosteroid-induced diabetes

The mechanism. Corticosteroids raise blood glucose directly and substantially. Long-term or high-dose steroid treatment causes hyperglycaemia and, in many people, diabetes.

Where this matters in disability: boys and young men with Duchenne muscular dystrophy on long-term corticosteroids, which preserve muscle function and are standard care. Also people on steroids for autoimmune conditions, after transplantation, for respiratory disease, and in some cancer regimens.

The thing that makes this different: stopping the steroid is frequently not an option, because the steroid is doing something important. So the diabetes has to be managed alongside a treatment that is causing it.

What to watch: steroid-induced hyperglycaemia characteristically rises later in the day following a morning dose, so a fasting glucose taken in the morning can look normal while afternoon and evening readings are high. Testing only in the morning will miss it. Where steroid doses change — a pulse, a taper, a stress dose during illness — glucose requirements change with them, sometimes sharply.

There is a guide on steroids and bone health in the muscular dystrophy library on this site; the glucose consequence belongs alongside it.

Autism

The mechanisms are several and they pull in different directions.

Medication. Antipsychotics are prescribed to autistic people at high rates in Australia, frequently for behaviour, and they cause weight gain and insulin resistance. The monitoring data is poor — an Australian study of children and adolescents newly prescribed antipsychotics found blood glucose checked in 12.9 per cent within twelve months. There is a full guide on this here.

Food selectivity. Restricted and repetitive eating patterns are common in autism, sometimes to the degree of avoidant restrictive food intake disorder. Diets can be narrow, energy-dense, and extremely difficult to change — and standard dietary advice that assumes flexibility is unusable. A dietitian experienced with autism is a materially different proposition from a general one.

Interoception — and this is the point worth knowing. Many autistic people experience reduced or atypical interoception, meaning difficulty perceiving and interpreting internal bodily states — hunger, thirst, pain, temperature, and the vague unwell feeling that signals a low blood glucose.

That has a direct safety implication: an autistic person on insulin may not reliably perceive the early symptoms of hypoglycaemia, even where they are entirely able to communicate. This is a different problem from the communication barrier described elsewhere in this library, and it is not something to be overcome by asking better questions.

Where it applies, the case for continuous glucose monitoring is strong, because the alarm supplies what interoception does not. It is worth raising explicitly with the diabetes team as a clinical reason rather than a preference.

Sensory barriers. Finger pricks and injections are sensory events, and distress about them may be sensory rather than fearful. Lancet depth, site, device type, predictability and warning all matter. And a person who cannot tolerate a finger prick four times a day is a strong candidate for sensor-based monitoring.

Psychosocial disability and mental illness

The relationship runs both ways. Antipsychotics and some mood stabilisers cause weight gain and insulin resistance. Separately, diabetes is associated with roughly double the rate of depression, and depression makes diabetes self-management substantially harder — which worsens control, which worsens mood.

What gets missed: people with serious mental illness have markedly reduced life expectancy, and cardiometabolic disease is the largest contributor. Metabolic monitoring rates are low. Clozapine in particular carries high metabolic risk alongside its specific monitoring requirements for other reasons, which means the monitoring infrastructure exists and the metabolic parameters still get skipped.

What to do: treat metabolic monitoring as a routine part of psychotropic prescribing rather than something that happens if somebody remembers, and treat depression as a diabetes issue rather than a separate one.

Acquired brain injury and stroke

The mechanism. Diabetes is a major risk factor for stroke, so the two frequently coexist. And brain injury affects the cognitive functions diabetes self-management depends on — memory, planning, initiation, sequencing, and the ability to notice and act on a change.

What gets missed: somebody with good language skills and intact social presentation may be entirely unable to initiate a sequence of tasks reliably. Executive impairment after brain injury is invisible in conversation and devastating for a regimen requiring four daily decisions.

What works: external structure rather than reminders to try harder. Alarms, prefilled devices, a written sequence in a fixed place, a routine tied to existing events rather than clock times, and somebody checking rather than asking. There is a separate guide on self-management adaptations here.

Also worth knowing: pituitary and hypothalamic injury after traumatic brain injury can affect multiple hormone systems and is under-diagnosed.

Dementia, where the problem is usually the opposite

This one needs stating because it runs against the instinct of everybody involved.

In older people with dementia and type 2 diabetes, the most common diabetes problem is not inadequate treatment. It is overtreatment.

The reasoning: tight glycaemic control reduces long-term complication risk over years to decades. It also increases hypoglycaemia risk now. In somebody with advanced dementia and a limited time horizon, the long-term benefit may never be realised, while the hypoglycaemia risk is immediate — and hypoglycaemia in dementia is particularly dangerous, because the person cannot report symptoms, confusion is already their baseline so a hypo is invisible, falls risk is high, and severe hypoglycaemia may worsen cognition further.

So de-intensification — relaxing the target, reducing or stopping medication, particularly sulfonylureas and insulin — is frequently the clinically appropriate direction. This is a well-recognised principle in geriatric diabetes care and it is applied less often than it should be, partly because reducing treatment feels like giving up.

What to raise with the GP or geriatrician: is the current HbA1c target appropriate for this person’s situation, and is the regimen creating more risk than it removes? That is a legitimate and important question, and it is rarely asked by families who assume more treatment is better.

And the sulfonylurea point specifically. Gliclazide and similar drugs cause prolonged hypoglycaemia and are a recognised cause of harm in frail older people. In somebody with dementia living alone or with intermittent support, they deserve particular scrutiny.

Vision impairment

Covered in its own guide here, but the headline: diabetes can cause the vision loss that then makes managing diabetes harder, and the adaptations that solve it — talking meters, insulin pens with audible clicks and tactile markers, magnification, and sensor-based monitoring with audio alerts — are readily available and routinely not offered.

The common thread

Across all of these, three things recur.

Standard advice assumes a standard body, and where muscle mass, nutrition priorities, sensation, interoception or life expectancy differ, the advice needs adjusting by somebody who knows both conditions.

The two clinical teams rarely talk. The diabetes team and the disability or specialty team are different appointments, and the interaction between the conditions falls between them. A Medicare-funded case conference — items 735, 739 and 743 for a GP organising, coordinating or participating, and 747, 750 and 758 where at least two other health professionals are involved — is the mechanism that gets them into one conversation with one plan. Ask the GP for one.

Somebody has to hold the whole picture, and in practice it is a family member, a support coordinator or a GP who has decided to.